Received Mar 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | — | — |
instead of pneumococcal vaccine they administered a Pediarix dose; instead of pneumococcal vaccine they administered a Pediarix dose; patient received 2 prior Pediarix doses on November 18th 2024 and February 12th 2025; This non-serious case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too long in a 4-month-old male patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis and Pneumococcal vaccine for prophylaxis. Previously administered products included Hepatitis B (Received on 18-SEP-2024). Concomitant products included PEDIARIX. On 18-FEB-2025, the patient received the 3rd dose of Pediarix. On 12-FEB-2025, the patient received the 2nd dose of Pediarix. On an unknown date, the patient received Pneumococcal vaccine. On 12-FEB-2025, not applicable after receiving Pediarix and an unknown time after receiving Pediarix, the patient experienced drug dose administration interval too long (Verbatim: patient received 2 prior Pediarix doses on November 18th 2024 and February 12th 2025). On 18-FEB-2025, the patient experienced wrong vaccine administered (Verbatim: instead of pneumococcal vaccine they administered a Pediarix dose) and drug dose administration interval too short (Verbatim: instead of pneumococcal vaccine they administered a Pediarix dose). The outcome of the drug dose administration interval too long, wrong vaccine administered and drug dose administration interval too short were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 19-FEB-2025 The physician reported that a patient came for a pneumococcal vaccine but instead of that one they administered a Pediarix dose (as 3rd dose) which led to wrong vaccine administered and shortening of vaccine schedule. The patient received 2nd dose of Pediarix later than the recommended interval, which led to lengthening of vaccine schedule. The reporter did not have lot numbers or expiration dates for any of the vaccines.
PEDIARIX